[1]
2013. Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?. Journal of Cancer Research Updates. 2, 4 (Nov. 2013),  297–305. DOI:https://doi.org/10.6000/1929-2279.2013.02.04.8.